EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma

EGFR Gene Alterations in a Norwegian Cohort of Lung Cancer Patients Selected for Surgery

(2011) Åslaug Helland et al.   Journal of Thoracic Oncology

EGFR fluorescence in situ hybridization-positive lung adenocarcinoma: incidence of coexisting KRAS and BRAF mutations

(2010) Simion Chiosea et al.   HUMAN PATHOLOGY

Spectrum of LKB1, EGFR, and KRAS Mutations in Chinese Lung Adenocarcinomas

(2010) Bin Gao et al.   Journal of Thoracic Oncology

Somatic Mutations in Epidermal Growth Factor Receptor Signaling Pathway Genes in Non-small Cell Lung Cancers

(2010) Shin Yup Lee et al.   Journal of Thoracic Oncology

EGFR/KRAS/BRAF Mutations in Primary Lung Adenocarcinomas and Corresponding Locoregional Lymph Node Metastases

(2009) K. Schmid et al.   CLINICAL CANCER RESEARCH

Genetic Abnormalities of theEGFRPathway in African American Patients With Non–Small-Cell Lung Cancer

(2009) Rom S. Leidner et al.   JOURNAL OF CLINICAL ONCOLOGY

Detection of EGFR and KRAS mutations on trans-thoracic needle aspiration of lung nodules by high resolution melting analysis

(2009) A Fassina et al.   JOURNAL OF CLINICAL PATHOLOGY

Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer

(2009) Rafael Rosell et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer

(2008) C.-H. Gow et al.   ANNALS OF ONCOLOGY

Radiotherapy in Lung Adenocarcinoma with Brain Metastases: Effects of Activating Epidermal Growth Factor Receptor Mutations on Clinical Response

(2008) C.-H. Gow et al.   CLINICAL CANCER RESEARCH

Lung Cancer with Epidermal Growth Factor Receptor Exon 20 Mutations Is Associated with Poor Gefitinib Treatment Response

(2008) J.-Y. Wu et al.   CLINICAL CANCER RESEARCH

Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma

(2008) S-G. Wu et al.   EUROPEAN RESPIRATORY JOURNAL

Specific EGFR Mutations Predict Treatment Outcome of Stage IIIB/IV Patients With Chemotherapy-Naive Non–Small-Cell Lung Cancer Receiving First-Line Gefitinib Monotherapy

(2008) Chih-Hsin Yang et al.   JOURNAL OF CLINICAL ONCOLOGY

Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer

(2008) Helena Linardou et al.   LANCET ONCOLOGY